Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time

CMV-, EBV- and ADV-Specific T Cell Immunity: Screening and Monitoring of Potential Third-Party Donors to Improve Post-Transplantation Outcome

(2013) Cinja Sukdolak et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation

(2013) Simona Iacobelli et al.   BONE MARROW TRANSPLANTATION

Human Herpesvirus 6 (HHV-6) Reactivation and HHV-6 Encephalitis After Allogeneic Hematopoietic Cell Transplantation: A Multicenter, Prospective Study

(2013) Masao Ogata et al.   CLINICAL INFECTIOUS DISEASES

Does matched unrelated donor transplantation have the same outcome as matched sibling transplantation in unselected patients?

(2012) Mary M. Horowitz   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia

(2012) W. Saber et al.   BLOOD

Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry

(2012) S Kurosawa et al.   BONE MARROW TRANSPLANTATION

Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen

(2012) J Sanz et al.   BONE MARROW TRANSPLANTATION

Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative conditioning regimens

(2012) S.-H. Kim et al.   Transplant Infectious Disease

Adoptive immunotherapy with virus-specific T cells

(2011) Shigeo Fuji et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

CMV Infection after Transplant from Cord Blood Compared to Other Alternative Donors: The Importance of Donor-Negative CMV Serostatus

(2011) Małgorzata Mikulska et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Reducing the Risk for Transplantation-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?

(2011) John T. Horan et al.   JOURNAL OF CLINICAL ONCOLOGY

Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients

(2010) Nishitha Reddy et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

How I treat: the selection and acquisition of unrelated cord blood grafts

(2010) J. N. Barker et al.   BLOOD

Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution

(2010) R Martino et al.   BONE MARROW TRANSPLANTATION

Cidofovir for BK Virus–Associated Hemorrhagic Cystitis: A Retrospective Study

(2009) Simone Cesaro et al.   CLINICAL INFECTIOUS DISEASES

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction

(2009) H. Omar et al.   Transplant Infectious Disease

Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia

(2008) Y. Atsuta et al.   BLOOD

Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor

(2008) G Bautista et al.   BONE MARROW TRANSPLANTATION

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES